Manufacturer record
Maa Pharma Tech: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Maa Pharma Tech (Gujarat) were declared Not of Standard Quality between July 2021 and March 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Maa Pharma Tech in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol, Phenyephrine hydrochloride & Chlorpheniramine Maleate Syrup | ML24224Mfg 2024-11 · Exp 2026-10 | Phenyephrine hydrochloride contentOther | FDL, VadodaraState lab | Mar 2026 |
| Calastravit -500 (Calcium with Vitamin D3 Tablets IP) | MT20013Mfg 2020-10 · Exp 2022-09 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.